Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

VK2735

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Viking Therapeutics · Phase 3 · Active, not recruiting · Enrollment 1100

NCT07104383

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Placebo Assignmentn/rn/rn/rn/r
Active Assignment (Dose #1)n/rn/rn/rn/r
Active Assignment (Dose #2)n/rn/rn/rn/r
Active Assignment (Dose #3)n/rn/rn/rn/r

Not shown

  • Placebo Assignment: endpoint not reported
  • Active Assignment (Dose #1): endpoint not reported
  • Active Assignment (Dose #2): endpoint not reported
  • Active Assignment (Dose #3): endpoint not reported